申请人:HOFFMANN LA ROCHE
公开号:WO2011151357A1
公开(公告)日:2011-12-08
Compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein: wherein m, n, p, q, X Y, Z, A, R1, R2, R3, R4, R5 and Y6 are as defined herein. The compounds and compositions disclosed herein are useful to modulate the activity of JNK and treat diseases associated with JNK activity.